查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421595

藥物發現服務市場、份額、規模、趨勢、產業分析報告：按類型、最終用途、地區、細分市場預測，2024-2032 年

Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球藥物發現服務市場預計將達到640.8億美元。 藥物發現服務市場份額、規模、趨勢、行業分析報告，按類型（小分子、聚合物）、最終用途、地區、細分市場、預測報告，2024-2032 年它提供了詳細的見解深入了解當前市場動態並對未來市場成長進行分析。

尋找適合治療或控制疾病的物質的過程稱為藥物發現。 尋找潛在藥物通常從表現出有吸引力的生物特性或與已知參與疾病發展的生物標靶相互作用的分子開始。

最近的技術進步徹底改變了藥物發現的格局，使其成為一個更加複雜、更精確和耗時的領域。 過去，藥物開發主要依靠確定傳統藥物中的活性成分，一個典型的例子就是青黴素的發現。

製藥業對創新和有效治療方法的不懈追求正在推動研發 (R&D) 預算的大幅增加。 隨著全球疾病負擔持續增加，對解決未滿足的醫療需求的新藥的需求不斷增長。 因此，製藥公司越來越有動力增加研發投資，以尋找突破性的治療方法。 這種不斷增長的承諾正在推動對藥物發現服務不斷增長的需求。

由於科學知識和技術的進步，藥物發現研究的狀況正在發生顯著變化。 基因組學、蛋白質組學、高通量篩選、計算模型和其他尖端工具的出現使識別和開發新候選藥物的過程變得複雜。 這些突破需要對專業設備、專業知識和基礎設施進行大量投資，導致研發成本高昂。

由於 COVID-19 大流行，藥物發現服務市場發生了重大變化，影響了該行業的許多方面。 這場全球健康危機使傳染病成為人們關注的焦點。 對 COVID-19 治療和疫苗的迫切需求刺激了傳染病研究和開發領域的大量投資和合作。 許多提供藥物發現服務的公司已將重點轉向開發專門用於對抗這種病毒的藥物和治療方法。 這項變更增加了對確定目標、優化先導化合物以及進行傳染病臨床前測試的服務的需求。

此外，國家醫學圖書館 2021 年 6 月發表的一項研究強調了冠狀動脈疾病 (CAD) 對全球健康的重大影響。 光是 CAD 每年就導致約 61 萬人死亡，佔估計死亡人數的四分之一，是美國的第一大死因。 隨著 CAD 發生率的增加，對有效的冠狀動脈支架裝置的需求不斷增長，以滿足這一緊迫的醫療需求。 因此，預計這一因素將在預測期內推動冠狀動脈支架的需求。

藥物發現服務市場報告重點

  • 2022 年，小分子細分市場在藥物發現服務市場中佔據最大的收入份額。 由於尺寸小，小分子因其能夠輕鬆穿過細胞膜並精確靶向細胞內途徑而受到重視。 小分子由於其眾多優點，在藥物發現中的使用變得越來越流行。 多年來，製藥業已經成功地創造了基於小分子的藥物，這些藥物已被證明可以有效治療多種疾病。
  • 在預測期內，製藥業佔據最大的市場份額。 在尋找能夠帶來突破性治療的新候選藥物的願望的推動下，公司正在投入大量資源進行研究和開發。 製藥和生物技術公司在藥物開發方面表現出色，並與合約研究組織和服務提供者保持策略合作夥伴關係。 這些合作關係使我們能夠利用藥物發現服務提供者的專業技能和資源，使藥物發現過程更加有效和有效率。
  • 北美將在 2022 年成為最大市場，北美製藥和生物技術產業正在蓬勃發展，在推動藥物發現服務需求方面發揮著至關重要的作用。 非洲大陸也擁有強大而持久的研究生態系統，由著名的研究中心、著名的學術機構和強有力的政府支持組成，所有這些都有助於科學事業的進步。 大量高技能研究人員和科學家以及尖端技術能力進一步加強了該地區的市場領導地位。
  • 由於製藥業的擴張，亞太地區在藥物發現服務市場中成長最快，但其成功歸因於多種因素。 首先，該地區慢性生活方式疾病的盛行率正在增加，公司正在投資開發這些疾病的治療方法。 其次，該地區生物製藥公司數量的增加增加了藥物發現服務的機會並促進了市場成長。
  • 最後，採用有效的業務策略和區域合作預計將對市場產生重大的正面影響。 此外，旨在促進研究和開發的政府舉措，加上有利的監管框架和稅收優惠，進一步支持了該地區的市場成長。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球藥物發現服務市場洞察

  • 藥物發現服務市場 - 產業概況
  • 藥物發現服務市場動態
    • 推動者和機會
      • 眾多處理流程對新處理方法的需求不斷增加
      • 製藥和生技領域的研發支出增加
    • 抑制因素和挑戰
      • 嚴格監管藥物發現和動物使用
  • 杵分析
  • 藥物發現服務業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章全球藥物發現服務市場，依類型

  • 主要調查結果
  • 簡介
  • 小分子
  • 聚合物

第 6 章全球藥物發現服務市場，依最終用途劃分

  • 主要調查結果
  • 簡介
  • 醫學
  • 生物技術
  • 學術
  • 其他

第 7 章全球藥物發現服務市場（按地區）

  • 主要調查結果
  • 簡介
    • 2019-2032 年藥物發現服務市場評估（按地區）
  • 藥物發現服務市場 - 北美
    • 北美：藥物發現服務市場（以最終用途），2019-2032 年
    • 北美：藥物發現服務市場（按類型），2019-2032 年
    • 藥物發現服務市場 - 美國
    • 藥物發現服務市場 - 加拿大
  • 藥物發現服務市場 - 歐洲
    • 歐洲：藥物發現服務市場（以最終用途），2019-2032 年
    • 歐洲：藥物發現服務市場（按類型），2019-2032 年
    • 藥物發現服務市場 - 英國
    • 藥物發現服務市場 - 法國
    • 藥物發現服務市場 - 德國
    • 藥物發現服務市場 - 義大利
    • 藥物發現服務市場 - 西班牙
    • 藥物發現服務市場 - 荷蘭
    • 藥物發現服務市場 - 俄羅斯
  • 藥物發現服務市場 - 亞太地區
    • 亞太地區：藥物發現服務市場（以最終用途），2019-2032 年
    • 亞太地區：藥物發現服務市場（按類型），2019-2032 年
    • 藥物發現服務市場 - 中國
    • 藥物發現服務市場 - 印度
    • 藥物發現服務市場 - 馬來西亞
    • 藥物發現服務市場—日本
    • 藥物發現服務市場—印度尼西亞
    • 藥物發現服務市場－韓國
  • 藥物發現服務市場 - 中東/非洲
    • 中東和非洲：藥物發現服務市場（以最終用途），2019-2032 年
    • 中東和非洲：藥物發現服務市場（按類型），2019-2032 年
    • 藥物發現服務市場 - 沙烏地阿拉伯
    • 藥物發現服務市場 - 阿拉伯聯合大公國
    • 藥物發現服務市場 - 以色列
    • 藥物發現服務市場 - 南非
  • 藥物發現服務市場 - 拉丁美洲
    • 拉丁美洲：藥物發現服務市場（以最終用途），2019-2032 年
    • 拉丁美洲：藥物發現服務市場（按類型），2019-2032 年
    • 藥物發現服務市場 - 墨西哥
    • 藥物發現服務市場 - 巴西
    • 藥物發現服務市場 - 阿根廷

第八章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第九章公司簡介

  • Aurigene Discovery Technologies
  • Charles River Laboratories International Inc.
  • Eurofins Scientific
  • Evotec
  • Frontage Labs
  • Galapagos NV
  • General Electric
  • Genscript
  • Laboratory Corporations of America Holdings
  • PPD Inc.
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: PM3920

The global drug discovery services market size is expected to reach USD 64.08 Billion by 2032, according to a new study by Polaris Market Research. The "Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast report, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The process of searching for a substance suitable for treating and controlling diseases is known as drug discovery. Typically, the quest for a potential drug starts with a molecule displaying fascinating biological characteristics or interacting with a biological target known to play a role in the advancement of a disease.

Recent technological progress has transformed the landscape of drug discovery, elevating it to a realm of greater sophistication, precision, and increased time investment. In the past, drug development primarily relied on pinpointing the active constituents within traditional remedies, a prime example being the discovery of penicillin.

The pharmaceutical industry's relentless pursuit of innovative and effective therapeutics is prompting a significant increase in research and development (R&D) budgets. As the global disease burden continues to escalate, there is a growing call for new medications capable of addressing unmet medical needs. Consequently, pharmaceutical companies are increasingly motivated to augment their R&D investments in the quest for groundbreaking treatments. This heightened commitment, in turn, fuels a rising demand for drug discovery services.

The landscape of drug discovery research has evolved significantly due to advancements in scientific knowledge and technology. The emergence of genomics, proteomics, high-throughput screening, computational modeling, and other state-of-the-art tools has intricately transformed the process of identifying and developing new drug candidates. These breakthroughs necessitate substantial investments in specialized equipment, expertise, and infrastructure, consequently leading to an escalation in R&D expenditures.

The drug discovery services market underwent a profound transformation due to the COVID-19 pandemic, impacting multiple facets of the industry. This global health crisis intensified the spotlight on infectious diseases. The pressing demand for COVID-19 treatments and vaccines spurred substantial investments and collaborations within the realm of infectious disease research and development. Numerous providers of drug discovery services pivoted their focus toward the development of drugs and treatments designed specifically to combat the virus. This change led to a growing need for services related to identifying targets, optimizing leads, and conducting preclinical testing for infectious diseases.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.

Drug Discovery Services Market Report Highlights

  • In 2022, the small molecule segment held the largest revenue share in the drug discovery services market, small molecules are highly valued for their small size, which enables them to easily pass through cell membranes and precisely target intracellular pathways. The use of small molecules in drug discovery has become increasingly popular due to their numerous advantages. For many years, the pharmaceutical industry has successfully created drugs based on small molecules, proving their effectiveness in treating a wide range of medical conditions.
  • The pharmaceutical segment accounted for the largest market share during the forecast period. Companies allocate significant resources to research and development, driven by the desire to discover new drug candidates that can lead to groundbreaking treatments. Pharmaceutical and biotechnology firms excel in drug development and maintain strategic partnerships with contract research organizations and service providers. These collaborations enable them to leverage the specialized skills and resources of drug discovery service providers, resulting in more effective and efficient drug discovery processes.
  • In 2022, North America dominated the largest market, North America's pharmaceutical and biotechnology sectors are thriving, playing a pivotal role in driving the demand for drug discovery services. The continent is also home to a robust and enduring research ecosystem comprising renowned research centers, prestigious academic institutions, and strong government support, all contributing to advancing scientific endeavors. The region's market leadership is further bolstered by its abundance of highly skilled researchers, scientists, and state-of-the-art technological capabilities.
  • The Asia-Pacific region accounted for the fastest growth in the Drugs Discovery Services Market due to the expansion of the pharmaceutical sector owes its success to a variety of factors. Firstly, the rising incidence of chronic lifestyle-related illnesses within the region has driven companies to invest in developing treatments for these conditions. Secondly, the increasing number of biopharmaceutical enterprises in the area has created more opportunities for drug discovery services, thus fueling market growth.
  • Lastly, the adoption of effective business strategies and regional collaborations is expected to exert a significant positive influence on the market. Moreover, government initiatives aimed at promoting research and development, coupled with favorable regulatory frameworks and tax incentives, have further bolstered market growth in this region.
  • The global key market players include: Aurigene Discovery Technologies, Charles River Laboratories International Inc., Eurofins Scientific, Evotec, Frontage Labs, Galapagos NV, General Electric, Genscript, Laboratory Corporations of America Holdings, PPD Inc., Syngene International Limited, Thermo Fisher Scientific Inc., and WuXi AppTec.

Polaris Market Research has segmented the drug discovery services market report based on type, end-use, and region:

Drug Discovery Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Small Molecules
  • Large Molecules

Drug Discovery Services, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical
  • Biotechnology
  • Academics
  • Others

Drug Discovery Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Drug Discovery Services Market Insights

  • 4.1. Drug Discovery Services Market - Industry Snapshot
  • 4.2. Drug Discovery Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for novel therapies for numerous therapeutic processes
      • 4.2.1.2. Rising expenditure in R&D in pharmaceutical and biotechnology sector
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Rigorous regulations governing the drug discovery and animal usage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Drug Discovery Services Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Services Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Drug Discovery Services, by Type, 2019-2032 (USD Billion)
  • 5.3. Small Molecules
    • 5.3.1. Global Drug Discovery Services Market, by Small Molecules, by Region, 2019-2032 (USD Billion)
  • 5.4. Large Molecules
    • 5.4.1. Global Drug Discovery Services Market, by Large Molecules, by Region, 2019-2032 (USD Billion)

6. Global Drug Discovery Services Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • 6.3. Pharmaceutical
    • 6.3.1. Global Drug Discovery Services Market, by Pharmaceutical, by Region, 2019-2032 (USD Billion)
  • 6.4. Biotechnology
    • 6.4.1. Global Drug Discovery Services Market, by Biotechnology, by Region, 2019-2032 (USD Billion)
  • 6.5. Academics
    • 6.5.1. Global Drug Discovery Services Market, by Academics, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Drug Discovery Services Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Drug Discovery Services Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Drug Discovery Services Market - North America
    • 7.3.1. North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Drug Discovery Services Market - U.S.
      • 7.3.3.1. U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Drug Discovery Services Market - Canada
      • 7.3.4.1. Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Drug Discovery Services Market - Europe
    • 7.4.1. Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Drug Discovery Services Market - UK
      • 7.4.3.1. UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Drug Discovery Services Market - France
      • 7.4.4.1. France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Drug Discovery Services Market - Germany
      • 7.4.5.1. Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Drug Discovery Services Market - Italy
      • 7.4.6.1. Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Drug Discovery Services Market - Spain
      • 7.4.7.1. Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Drug Discovery Services Market - Netherlands
      • 7.4.8.1. Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Drug Discovery Services Market - Russia
      • 7.4.9.1. Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Drug Discovery Services Market - Asia Pacific
    • 7.5.1. Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Drug Discovery Services Market - China
      • 7.5.3.1. China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Drug Discovery Services Market - India
      • 7.5.4.1. India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Drug Discovery Services Market - Malaysia
      • 7.5.5.1. Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Drug Discovery Services Market - Japan
      • 7.5.6.1. Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Drug Discovery Services Market - Indonesia
      • 7.5.7.1. Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Drug Discovery Services Market - South Korea
      • 7.5.8.1. South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Drug Discovery Services Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Drug Discovery Services Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Drug Discovery Services Market - UAE
      • 7.6.4.1. UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Drug Discovery Services Market - Israel
      • 7.6.5.1. Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Drug Discovery Services Market - South Africa
      • 7.6.6.1. South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Drug Discovery Services Market - Latin America
    • 7.7.1. Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Drug Discovery Services Market - Mexico
      • 7.7.3.1. Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Drug Discovery Services Market - Brazil
      • 7.7.4.1. Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Drug Discovery Services Market - Argentina
      • 7.7.5.1. Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Aurigene Discovery Technologies
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Charles River Laboratories International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Eurofins Scientific
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Evotec
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Frontage Labs
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Galapagos NV
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. General Electric
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Genscript
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Laboratory Corporations of America Holdings
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. PPD Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Syngene International Limited
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Thermo Fisher Scientific Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. WuXi AppTec
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development

List of Tables

  • Table 1 Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 2 Global Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 5 North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 13 UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 31 India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Drug Discovery Services Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End-Use
  • Figure 7 Global Drug Discovery Services Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Drug Discovery Services Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Drug Discovery Services Market